Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Denning

Showing results (101-110 of 280) with videos related to

Pageof 28
Sort By:
Antimicrobial Agents and Chemotherapy|October 3, 1998
In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus sppK L Oakley, C B Moore, D W Denning
British Medical Journal (Clinical Research Ed.)|January 17, 1987
Acute myelopathy associated with primary infection with human immunodeficiency virusD W Denning, J Anderson, P Rudge, et al.
Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society for Human and Animal Mycology|January 1, 1992
Quantitative preservation of viability of Aspergillus fumigatusD W Denning, K V Clemons, D A Stevens
Chemotherapy|January 1, 1992
US experience with itraconazole in Aspergillus, Cryptococcus and Histoplasma infections in the immunocompromised hostJ S Hostetler, D W Denning, D A Stevens
Folia Microbiologica|September 21, 2000
Use of the 6-methylsalicylic-acid-synthase gene as a discriminating marker between Aspergillus terreus and Aspergillus flavipesS Pazoutová, I Hamplová, M Anderson, et al.
International Journal of Antimicrobial Agents|August 26, 1999
Activity of pradimicin BMS-181184 against Aspergillus sppK L Oakley, C B Moore, D W Denning
Antimicrobial Agents and Chemotherapy|May 17, 2001
In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin BC B Moore, C M Walls, D W Denning
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 1990
In vitro activity of saperconazole (R66 905) compared with amphotericin B and itraconazole against Aspergillus speciesD W Denning, L H Hanson, D A Stevens
Thorax|December 1, 1993
Unilateral wheeze caused by pseudomembranous aspergillus tracheobronchitis in the immunocompromised patientR C Tait, B R O'Driscoll, D W Denning
Infection and Immunity|March 1, 1996
Evidence of multiple extracellular phospholipase activities of Aspergillus fumigatusM Birch, G Robson, D Law, et al.
Pageof 28

Showing results (101-110 of 280) with videos related to

Sort By:
Pageof 28
Antimicrobial Agents and Chemotherapy|October 3, 1998
In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus sppK L Oakley, C B Moore, D W Denning
British Medical Journal (Clinical Research Ed.)|January 17, 1987
Acute myelopathy associated with primary infection with human immunodeficiency virusD W Denning, J Anderson, P Rudge, et al.
Journal of Medical and Veterinary Mycology : Bi-Monthly Publication of the International Society for Human and Animal Mycology|January 1, 1992
Quantitative preservation of viability of Aspergillus fumigatusD W Denning, K V Clemons, D A Stevens
Chemotherapy|January 1, 1992
US experience with itraconazole in Aspergillus, Cryptococcus and Histoplasma infections in the immunocompromised hostJ S Hostetler, D W Denning, D A Stevens
Folia Microbiologica|September 21, 2000
Use of the 6-methylsalicylic-acid-synthase gene as a discriminating marker between Aspergillus terreus and Aspergillus flavipesS Pazoutová, I Hamplová, M Anderson, et al.
International Journal of Antimicrobial Agents|August 26, 1999
Activity of pradimicin BMS-181184 against Aspergillus sppK L Oakley, C B Moore, D W Denning
Antimicrobial Agents and Chemotherapy|May 17, 2001
In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin BC B Moore, C M Walls, D W Denning
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 1990
In vitro activity of saperconazole (R66 905) compared with amphotericin B and itraconazole against Aspergillus speciesD W Denning, L H Hanson, D A Stevens
Thorax|December 1, 1993
Unilateral wheeze caused by pseudomembranous aspergillus tracheobronchitis in the immunocompromised patientR C Tait, B R O'Driscoll, D W Denning
Infection and Immunity|March 1, 1996
Evidence of multiple extracellular phospholipase activities of Aspergillus fumigatusM Birch, G Robson, D Law, et al.
Pageof 28